companydirectorylist.com  Global Business Directory e directory aziendali
Ricerca Società , Società , Industria :


elenchi dei paesi
USA Azienda Directories
Canada Business Elenchi
Australia Directories
Francia Impresa di elenchi
Italy Azienda Elenchi
Spagna Azienda Directories
Svizzera affari Elenchi
Austria Società Elenchi
Belgio Directories
Hong Kong Azienda Elenchi
Cina Business Elenchi
Taiwan Società Elenchi
Emirati Arabi Uniti Società Elenchi


settore Cataloghi
USA Industria Directories














  • List of 72 Multiple Sclerosis Medications Compared - Drugs. com
    Treatments for Multiple Sclerosis can be grouped into those used for relapses (such as corticosteroids or plasma exchange), those that slow down the progression of MS and reduce the number of relapses (such as Avonex, Rebif, Copaxone, Glatopa, Kesimpta, Aubagio, Tecfidera, Vumerity, Bafiertam, Gilenya, Mayzent, Zeposia, Ponvory, Mavenclad, Tysabri, Ocrevus, or Lemtrada) and those that treat
  • Treatments and Medications - National Multiple Sclerosis Society
    Multiple sclerosis symptoms are variable and unpredictable No two people have exactly the same symptoms, and each person’s symptoms can change or fluctuate over time In addition to early and ongoing treatment with a disease-modifying therapy , you have many options for managing your MS
  • MS Medications: Injections, Infusions, and Oral Drugs
    Multiple sclerosis (MS) drugs can modify disease progression, treat relapses, and more Learn about over 50 MS drugs, like Tecfidera and Ocrevus
  • MS Drugs: Disease-Modifying Drugs to Treat and Slow MS . . .
    WebMD looks at disease-modifying drugs, their uses and side effects , and explains how they slow the progression of multiple sclerosis
  • Multiple sclerosis - Diagnosis and treatment - Mayo Clinic
    Well, the first drug approved by the FDA for treatment of multiple sclerosis was in 1993 Since then, over 20 drugs have become available for treatment of MS And the potency of these drugs has increased over time to the point where we can almost completely suppress the inflammatory component of the disease




Annuari commerciali , directory aziendali
Annuari commerciali , directory aziendali copyright ©2005-2012 
disclaimer